fda news tirzepatide The has approved the drug Zepbound, which is similar to both Ozempic and Wegovy. The drug's active ingredient is called tirzepatide, and it was originally a diabetes drug sold under the FDA approves weight-loss drug Zepbound
Description
Consumer genetic testing company 23andMe sees an opportunity to get in on the weight loss boom

Sales of antiobesity drugs hit $1.1 billion in the second quarter of 2023.

It plays a key role in regulating GLP-1 production, helping to control appetite and support natural weight management

Tirzepatide demonstrates cardiovascular benefits in clinical trials, including reduced heart attack and stroke risk in patients with obesity and type 2 diabetes

Fella Health reviewed: business model, compounded-pharmacy pathway, patient reports, and fair-balance safety
